United States Healthcare Equipment & Supplies

Generate Biomedicines Inc (GENB)

Track

Generate Biomedicines Inc experienced significant insider trading activity during early March 2026. Multiple executives and stakeholders executed substantial buy orders, with the most recent transaction occurring on March 4, 2026. These acquisitions involved millions of shares, reflecting notable capital deployment by leadership and associated parties well beyond the three-month window.
Ticker: GENB Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Generate Biomedicines Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.4
Nally Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
219.10
Quantity 89,514 +28.5%
Value US$4,128,651
Grous Beth Chief People Officer Officer
Transaction date
Purchase
Price
315.49
Quantity 32,157 -17.9%
Value US$3,030,743
Silvers Jason President & CFO Officer
Transaction date
Purchase
Price
80.74
Quantity 19,365 +9.8%
Value US$451,790
Silvers Jason President & CFO Officer
Transaction date
Purchase
Price
16.00
Quantity 500 +inf%
Value US$8,000
Silvers Jason President & CFO Officer
Transaction date
Purchase
Price
16.00
Quantity 500 +inf%
Value US$8,000
3.3
AFEYAN NOUBAR Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 1,562,500 +inf%
Value US$25,000,000
3.3
AFEYAN NOUBAR Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 1,562,500 +56.3%
Value US$25,000,000
3.3
AFEYAN NOUBAR Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 1,562,500 +11.4%
Value US$25,000,000
Mendillo Jane L Non-Executive Director
Transaction date
Purchase
Price
16.00
Quantity 1,500 +inf%
Value US$24,000
3.3
AFEYAN NOUBAR Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 1,562,500 +inf%
Value US$25,000,000
3.3
AFEYAN NOUBAR Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 1,562,500 +56.3%
Value US$25,000,000
3.3
AFEYAN NOUBAR Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 1,562,500 +11.4%
Value US$25,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-06 2026-03-04 B Purchase
2.4
Nally Michael

Chief Executive Officer

Executive Director
89,514 +28.5%
219.10
US$4,128,651 		89,514 +28.5% 219.10 US$4,128,651
2026-03-02 2026-03-02 B Purchase
Grous Beth

Chief People Officer

Officer
32,157 -17.9%
315.49
US$3,030,743 		32,157 -17.9% 315.49 US$3,030,743
2026-03-02 2026-03-02 B Purchase
Silvers Jason

President & CFO

Officer
19,365 +9.8%
80.74
US$451,790 		19,365 +9.8% 80.74 US$451,790
2026-03-02 2026-03-02 B Purchase
Silvers Jason

President & CFO

Officer
500 +inf%
16.00
US$8,000 		500 +inf% 16.00 US$8,000
2026-03-02 2026-03-02 B Purchase
Silvers Jason

President & CFO

Officer
500 +inf%
16.00
US$8,000 		500 +inf% 16.00 US$8,000
2026-03-02 2026-03-02 B Purchase
3.3
AFEYAN NOUBAR
Non-Executive Director Large shareholder
1,562,500 +inf%
16.00
US$25,000,000 		1,562,500 +inf% 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase
3.3
AFEYAN NOUBAR
Non-Executive Director Large shareholder
1,562,500 +56.3%
16.00
US$25,000,000 		1,562,500 +56.3% 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase
3.3
AFEYAN NOUBAR
Non-Executive Director Large shareholder
1,562,500 +11.4%
16.00
US$25,000,000 		1,562,500 +11.4% 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase
Mendillo Jane L
Non-Executive Director
1,500 +inf%
16.00
US$24,000 		1,500 +inf% 16.00 US$24,000
2026-03-02 2026-03-02 B Purchase
3.3
AFEYAN NOUBAR
Non-Executive Director Large shareholder
1,562,500 +inf%
16.00
US$25,000,000 		1,562,500 +inf% 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase
3.3
AFEYAN NOUBAR
Non-Executive Director Large shareholder
1,562,500 +56.3%
16.00
US$25,000,000 		1,562,500 +56.3% 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase
3.3
AFEYAN NOUBAR
Non-Executive Director Large shareholder
1,562,500 +11.4%
16.00
US$25,000,000 		1,562,500 +11.4% 16.00 US$25,000,000
Explore more

More insider trading research around Generate Biomedicines Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America